87 related articles for article (PubMed ID: 5633274)
1. [Blood thyrotropic activity in patients with thyrotoxicosis].
Eskin IA; Skuratova NA; Kalinin AP; Konopatskaia VM
Probl Endokrinol (Mosk); 1967; 13(4):6-10. PubMed ID: 5633274
[No Abstract] [Full Text] [Related]
2. [Significance of thyrotropic function of the pituitary in pathogenesis of thyrotoxicosis].
LIVERGANT IuE
Probl Endokrinol Gormonoter; 1956; 2(4):32-41. PubMed ID: 13379296
[No Abstract] [Full Text] [Related]
3. [Effect of iodine preparations on the level of thyrotropic hormones in the blood in patients with thyrotoxicosis].
BRESLAVSKII AS; TSARIKOVSKAIA NG
Sov Med; 1959 Sep; 13():88-91. PubMed ID: 13804219
[No Abstract] [Full Text] [Related]
4. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
5. Thyrotoxicosis and Graves disease.
Safran M; Braverman LE
Hosp Pract (Off Ed); 1985 Mar; 20(3A):33-42, 46-9. PubMed ID: 3932411
[No Abstract] [Full Text] [Related]
6. [Thyrotropic hormone and the thyroid gland (present status)].
Kalinin AP; Izmaĭlov GI
Ter Arkh; 1977; 49(12):131-7. PubMed ID: 414369
[No Abstract] [Full Text] [Related]
7. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
8. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K
J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181
[No Abstract] [Full Text] [Related]
9. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
[No Abstract] [Full Text] [Related]
10. Evaluation of plasma thyrotrophin response to thyrotrophin releasing hormone in Graves' disease and in hyperactive thyroid adenoma before and after treatment.
Faglia G; Ferrari C; Beck-Peccoz P; Ambrosi B; Spada A; Travaglini P; Paracchi A
Folia Endocrinol; 1973 Aug; 26(4):245-56. PubMed ID: 4203132
[No Abstract] [Full Text] [Related]
11. Incomplete thyrotroph suppression determined by third generation thyrotropin assay in subacute thyroiditis compared to silent thyroiditis or hyperthyroid Graves' disease.
Ito M; Takamatsu J; Yoshida S; Murakami Y; Sakane S; Kuma K; Ohsawa N
J Clin Endocrinol Metab; 1997 Feb; 82(2):616-9. PubMed ID: 9024264
[TBL] [Abstract][Full Text] [Related]
12. [Use of plasmapheresis for the preoperative preparation of toxic goiter patients].
Neĭmark II; Katsevman AE; Dudarev VA; Slukhaĭ IuF
Vestn Khir Im I I Grek; 1985 Apr; 134(4):106-10. PubMed ID: 3839331
[TBL] [Abstract][Full Text] [Related]
13. [Biological determination of thyrotropin and long-acting thyroid simulator].
Potin VV; Stepanov GS
Probl Endokrinol (Mosk); 1969; 15(4):64-7. PubMed ID: 5395630
[No Abstract] [Full Text] [Related]
14. Graves' disease and selective resistance of pituitary thyrotroph to thyroid hormone. A case report.
Pillay NL; Jialal I; Govender PA; Green-Thompson RW; Joubert SM
S Afr Med J; 1986 Sep; 70(6):360-1. PubMed ID: 3092372
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of triiodothyronine thyrotoxicosis].
Semenov VD
Probl Endokrinol (Mosk); 1982; 28(6):32-5. PubMed ID: 6818538
[TBL] [Abstract][Full Text] [Related]
16. [Neonatal hyperthyroidism: a case report and literature review].
Li N; Li XH; Yao YM
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1557-9. PubMed ID: 24144770
[TBL] [Abstract][Full Text] [Related]
17. Experimental endocrine exophthalmos: II. Effect of patients' sera on radiosulfate incorporation.
Haddad HM; Loucas SP; Haddad H
Ann Ophthalmol; 1974 Nov; 6(11):1201-3, 1205. PubMed ID: 4479728
[No Abstract] [Full Text] [Related]
18. [Results of thyrostatic therapy of hyperthyroidism in patients with Basedow's disease and disseminated autonomy].
Meng W; Meng S; Hampel R; Ventz M; Männchen E; Weber W; Streckenbach B
Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):337-40. PubMed ID: 3129277
[TBL] [Abstract][Full Text] [Related]
19. Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease.
Feldkamp J; Pascher E; Schott M; Goretzki P; Seissler J; Scherbaum WA
J Clin Endocrinol Metab; 2001 Sep; 86(9):4250-3. PubMed ID: 11549657
[TBL] [Abstract][Full Text] [Related]
20. [Thyrotropic hormone plasma level in thyrotoxicosis].
Lozanov B; Visheva N
Vutr Boles; 1976; 15(5):30-3. PubMed ID: 1014608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
